Product NDC: | 0781-2617 |
Proprietary Name: | Rivastigmine Tartrate |
Non Proprietary Name: | rivastigmine tartrate |
Active Ingredient(s): | 6 mg/1 & nbsp; rivastigmine tartrate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-2617 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020823 |
Marketing Category: | NDA |
Start Marketing Date: | 20000430 |
Package NDC: | 0781-2617-13 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0781-2617-13) > 1 CAPSULE in 1 BLISTER PACK (0781-2617-06) |
NDC Code | 0781-2617-13 |
Proprietary Name | Rivastigmine Tartrate |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0781-2617-13) > 1 CAPSULE in 1 BLISTER PACK (0781-2617-06) |
Product NDC | 0781-2617 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rivastigmine tartrate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20000430 |
Marketing Category Name | NDA |
Labeler Name | Sandoz Inc |
Substance Name | RIVASTIGMINE TARTRATE |
Strength Number | 6 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |